Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers

Background: Ulcerative colitis (UC) is a chronic relapsing disease, which needs a continue monitoring, especially during biological therapies. An increasing number of patients is treated with anti-Tumor Necrosis factor (TNF) drugs, and current research is focalized to identify biomarkers able to mon...

詳細記述

保存先:
書誌詳細
出版年:Front Pharmacol
主要な著者: Capecchi, Riccardo, Migliorini, Paola, Zanzi, Federico, Maltinti, Simona, Puxeddu, Ilaria, de Bortoli, Nicola, Bellini, Massimo, Costa, Francesco, Marchi, Santino, Bertani, Lorenzo
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2021
主題:
Pharmacology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8062917/
https://ncbi.nlm.nih.gov/pubmed/33897440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.654319
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料